Annual Report 2023-24

100 Years of Trust In India

GSK's 100-year journey in India has drawn inspiration from the passion and commitment of its people. For 100 years your company has earned the trust of generations by consistently delivering high quality medicines and vaccines.

Company

A new era for human health

In India, we have a legacy of nearly 100 years. With our new purpose, strategy and culture, we will move #AheadTogether continuing our legacy in General Medicines, our leadership in the Vaccines self-pay market and introduce innovative offerings through our Specialty medicines.

We Are GSK
02:47
Close Video

Scroll to explore

Our strategy

We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

INFECTIOUS DISEASES
1 in 3
of us will be affected by shingles in our lifetime
HIV
38m
people are living with HIV worldwide
ONCOLOGY
~10m
people died from cancer in 2020, making it a leading cause of death worldwide
IMMUNOLOGY
25yrs
of leading research to help people with inflammatory conditions

BusinessWorld Sustainability Awards 2023-24

GSK India has been ranked #1 in the Pharma& Healthcare sector in Businessworld India's Most Sustainable Companies 2023-24.

Market Locations in India

​Our market locations in India

We are headquartered in Mumbai with a manufacturing facility at Nashik, Maharashtra, contract manufacturing organisations, regional and sales hubs across India.

Life at GSK in India

How we help people thrive

Careers at GSK India

Careers

Culture at GSK India

Culture

Opportunities at GSK India for Experienced Professionals

Experienced professionals

Early Talent Programmes at GSK India

Early talent

pinch icon pinch icon
Explore innovations in medicines and vaccines

Global behind the science magazine

Explore innovations in medicines and vaccines from inside and outside our global labs

Discover how we're getting ahead

In the spotlight

MEDIA

Press releases and other resources

Visit Media section

Investors

Shareholder information

Visit Shareholder information section

Responsibility

Responsible business

Visit Responsibility section